Dow Up 0.07% Nasdaq Up 0.61%

ImmunoGen, Inc. (IMGN)

-NasdaqGS
10.35 Up 0.51(5.18%) 4:00PM EST
Prev Close:9.84
Open:9.87
Bid:N/A
Ask:11.68 x 3000
1y Target Est:13.79
Beta:1.85
Earnings Date:Jan 29 - Feb 2 (Est.)
Day's Range:9.80 - 10.38
52wk Range:7.70 - 17.80
Volume:1,009,378
Avg Vol (3m):1,208,090
Market Cap:889.43M
P/E (ttm):N/A
EPS (ttm):-0.96
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
IMGNUp 5.18%889.43M
PFEUp 2.07%195.95B
RHHBYUp 0.54%254.20B
SGENUp 0.38%4.56B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):15.13
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Jun-15) :-0.69
Quarterly EPS Est (Dec-14) :-0.08
Mean Recommendation*:2.5
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

ImmunoGen, Inc., a biotechnology company, develops targeted anticancer therapeutics. It develops its products using its antibody-drug conjugates technology. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback